68.14
price down icon3.46%   -2.4895
 
loading
Schlusskurs vom Vortag:
$70.63
Offen:
$70.665
24-Stunden-Volumen:
6.61M
Relative Volume:
1.34
Marktkapitalisierung:
$26.73B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$571.50M
KGV:
47.70
EPS:
1.4285
Netto-Cashflow:
$570.80M
1W Leistung:
-2.24%
1M Leistung:
+1.62%
6M Leistung:
-4.20%
1J Leistung:
-5.43%
1-Tages-Spanne:
Value
$66.42
$70.67
1-Wochen-Bereich:
Value
$66.42
$72.08
52-Wochen-Spanne:
Value
$57.52
$93.25

Dexcom Inc Stock (DXCM) Company Profile

Name
Firmenname
Dexcom Inc
Name
Telefon
(858) 200-0200
Name
Adresse
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Mitarbeiter
10,300
Name
Twitter
@dexcom
Name
Nächster Verdiensttermin
2024-10-24
Name
Neueste SEC-Einreichungen
Name
DXCM's Discussions on Twitter

Vergleichen Sie DXCM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
DXCM
Dexcom Inc
68.16 27.70B 4.30B 571.50M 570.80M 1.4285
Medical Devices icon
ABT
Abbott Laboratories
126.58 221.35B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
101.25 151.78B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
377.56 146.70B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
93.59 120.73B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
82.41 47.45B 5.69B 1.41B 577.90M 6.9828

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-21 Fortgesetzt Stifel Buy
2025-09-08 Herabstufung Oppenheimer Outperform → Perform
2025-08-21 Eingeleitet Argus Buy
2025-06-16 Eingeleitet Truist Buy
2025-05-30 Eingeleitet Goldman Buy
2025-04-10 Eingeleitet Mizuho Outperform
2025-02-03 Hochstufung Redburn Atlantic Neutral → Buy
2025-01-16 Hochstufung Robert W. Baird Neutral → Outperform
2024-07-26 Herabstufung JP Morgan Overweight → Neutral
2024-07-26 Herabstufung Robert W. Baird Outperform → Neutral
2024-05-30 Eingeleitet Redburn Atlantic Neutral
2024-03-12 Eingeleitet RBC Capital Mkts Outperform
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-04-17 Hochstufung Raymond James Outperform → Strong Buy
2023-03-29 Eingeleitet UBS Buy
2023-01-26 Eingeleitet Wolfe Research Outperform
2022-10-18 Eingeleitet Barclays Equal Weight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-15 Eingeleitet Bernstein Outperform
2022-03-02 Fortgesetzt BofA Securities Buy
2022-02-03 Hochstufung BTIG Research Neutral → Buy
2022-01-19 Hochstufung Wells Fargo Equal Weight → Overweight
2022-01-07 Hochstufung Guggenheim Neutral → Buy
2021-10-18 Herabstufung Guggenheim Buy → Neutral
2021-07-21 Fortgesetzt Cowen Outperform
2021-05-28 Hochstufung Wells Fargo Underweight → Equal Weight
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Overweight
2021-01-06 Hochstufung UBS Neutral → Buy
2020-10-02 Herabstufung Wells Fargo Equal Weight → Underweight
2020-05-27 Bestätigt Piper Sandler Overweight
2020-05-14 Eingeleitet Wells Fargo Equal Weight
2020-03-05 Eingeleitet Citigroup Buy
2019-11-07 Bestätigt Canaccord Genuity Buy
2019-11-07 Hochstufung Guggenheim Neutral → Buy
2019-10-23 Eingeleitet Stifel Buy
2018-11-28 Eingeleitet UBS Neutral
2018-10-19 Hochstufung Goldman Sell → Neutral
2018-09-12 Hochstufung Northland Capital Under Perform → Market Perform
2018-08-02 Bestätigt Canaccord Genuity Buy
2018-07-02 Hochstufung Raymond James Mkt Perform → Outperform
2018-06-08 Hochstufung JP Morgan Neutral → Overweight
2018-05-11 Eingeleitet BofA/Merrill Buy
2018-05-03 Bestätigt Canaccord Genuity Buy
2018-04-04 Eingeleitet Goldman Sell
2018-04-04 Eingeleitet Guggenheim Neutral
2018-03-23 Hochstufung Robert W. Baird Neutral → Outperform
2018-01-04 Herabstufung Northland Capital Market Perform → Under Perform
2017-09-28 Bestätigt Wedbush Outperform
Alle ansehen

Dexcom Inc Aktie (DXCM) Neueste Nachrichten

pulisher
02:04 AM

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor - Benzinga

02:04 AM
pulisher
02:02 AM

DexCom (DXCM) Shares Dip as Hunterbrook Issues Short Report - GuruFocus

02:02 AM
pulisher
01:50 AM

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed DexCom, Inc. (DXCM) - GlobeNewswire Inc.

01:50 AM
pulisher
01:35 AM

DexCom falls as Hunterbrook releases new short report (DXCM:NASDAQ) - Seeking Alpha

01:35 AM
pulisher
11:54 AM

DexCom Shares Fall After Hunterbrook Report on Incidents Related to G7 Glucose Monitor - MarketScreener

11:54 AM
pulisher
11:43 AM

Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices - Stocktwits

11:43 AM
pulisher
11:36 AM

Dexcom (DXCM) Faces Scrutiny Following Reports of Glucose Monito - GuruFocus

11:36 AM
pulisher
11:36 AM

DexCom (DXCM) Shares Fall 2% Following Short Report - GuruFocus

11:36 AM
pulisher
11:22 AM

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

11:22 AM
pulisher
10:36 AM

Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption? - TradingView

10:36 AM
pulisher
10:35 AM

AstraZeneca non-executive director Euan Ashley joins DexCom board - Investing.com

10:35 AM
pulisher
10:24 AM

AstraZeneca non-executive director Euan Ashley joins DexCom board By Investing.com - Investing.com UK

10:24 AM
pulisher
08:02 AM

Will breakout in DexCom Inc. lead to full recovery2025 Analyst Calls & Fast Moving Market Watchlists - newser.com

08:02 AM
pulisher
06:25 AM

Can technical indicators confirm DexCom Inc.’s reversalPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com

06:25 AM
pulisher
06:07 AM

DexCom: Powering The Future Of Glucose Monitoring And Digital Care - RTTNews

06:07 AM
pulisher
02:25 AM

What catalysts could drive DexCom Inc. stock higherTrade Exit Report & Consistent Profit Trading Strategies - newser.com

02:25 AM
pulisher
02:06 AM

Is DexCom Inc. (DC4) stock a buy for dividend portfolios2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com

02:06 AM
pulisher
01:13 AM

DexCom Inc. stock daily chart insightsJuly 2025 Update & Safe Capital Allocation Plans - newser.com

01:13 AM
pulisher
Oct 27, 2025

Is DexCom Inc. stock reversal real or fakeMarket Growth Report & Risk Managed Investment Entry Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

DexCom Inc. stock chart pattern explainedWeekly Profit Analysis & AI Based Trade Execution Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What does recent volatility data suggest for DexCom Inc.Watch List & Fast Gaining Stock Strategy Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will DexCom Inc. stock maintain momentum in 2025Quarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom appoints Stanford’s Euan Ashley to board of directors - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom appoints Stanford’s Euan Ashley to board of directors By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom appoints Euan Ashley to board of directors - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom Appoints Euan Ashley To Board Of Directors - TradingView

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom Appoints Euan Ashley to Board of Directors - The Joplin Globe

Oct 27, 2025
pulisher
Oct 27, 2025

DexCom, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo

Oct 27, 2025
pulisher
Oct 27, 2025

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal

Oct 27, 2025
pulisher
Oct 27, 2025

Can DexCom Inc. stock sustain free cash flow growthTrade Analysis Report & Weekly High Return Stock Forecasts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is DexCom Inc. stock attractive for passive investorsDay Trade & Weekly Top Stock Performers List - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What MACD and RSI say about DexCom Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will a bounce in DexCom Inc. offer an exit2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What MACD trends signal for DexCom Inc. (DC4) stockEarnings Trend Report & Expert Approved Momentum Ideas - newser.com

Oct 27, 2025

Finanzdaten der Dexcom Inc-Aktie (DXCM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices PHG
$27.28
price down icon 5.57%
medical_devices STE
$240.43
price down icon 0.24%
$323.91
price down icon 0.52%
$79.33
price up icon 1.21%
medical_devices EW
$82.41
price up icon 1.95%
Kapitalisierung:     |  Volumen (24h):